125 related articles for article (PubMed ID: 38088568)
1. Linagliptin in combination with insulin suppresses apoptotic unfolded protein response in ovaries exposed to type 1 diabetes.
Okan A; Demir N; Doğanyiğit Z
Cell Biochem Funct; 2024 Mar; 42(2):e3898. PubMed ID: 38088568
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart.
Doğanyiğit Z; Okan A; Taheri S; Yılmaz Z; Akyüz E; Demir N
Chem Biol Drug Des; 2023 Nov; 102(5):1085-1096. PubMed ID: 37532256
[TBL] [Abstract][Full Text] [Related]
3. Activation of endoplasmic reticulum stress mediates oxidative stress-induced apoptosis of granulosa cells in ovaries affected by endometrioma.
Kunitomi C; Harada M; Takahashi N; Azhary JMK; Kusamoto A; Nose E; Oi N; Takeuchi A; Wada-Hiraike O; Hirata T; Hirota Y; Koga K; Fujii T; Osuga Y
Mol Hum Reprod; 2020 Jan; 26(1):40-52. PubMed ID: 31869409
[TBL] [Abstract][Full Text] [Related]
4. Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice.
Santos FO; Correia BRO; Marinho TS; Barbosa-da-Silva S; Mandarim-de-Lacerda CA; Souza-Mello V
Mol Cell Endocrinol; 2020 Jun; 509():110804. PubMed ID: 32259637
[TBL] [Abstract][Full Text] [Related]
5. Unfolded protein response triggers differential apoptotic mechanisms in ovaries and early embryos exposed to maternal type 1 diabetes.
Okan A; Demir N; Sozen B
Sci Rep; 2021 Jun; 11(1):12759. PubMed ID: 34140543
[TBL] [Abstract][Full Text] [Related]
6. Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice.
Nirwan N; Vohora D
Front Endocrinol (Lausanne); 2022; 13():944323. PubMed ID: 35928902
[TBL] [Abstract][Full Text] [Related]
7. The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome.
Kabel AM; Al-Shehri AH; Al-Talhi RA; Abd Elmaaboud MA
Chem Biol Interact; 2017 Aug; 273():190-199. PubMed ID: 28619389
[TBL] [Abstract][Full Text] [Related]
8. Peroxiredoxin I maintains luteal function by regulating unfolded protein response.
Park HJ; Lee DG; Seong JB; Lee HS; Kwon OS; Kang BS; Park JW; Lee SR; Lee DS
Reprod Biol Endocrinol; 2018 Aug; 16(1):79. PubMed ID: 30111318
[TBL] [Abstract][Full Text] [Related]
9. DPP-4 inhibitor linagliptin ameliorates imiquimod-induced psoriasis-like skin alterations in type 2 diabetic mice by inhibiting the MAPK/NF-κB inflammatory pathway.
Shao Z; Li X; Xu X; Chen P
Drug Dev Res; 2022 Sep; 83(6):1373-1382. PubMed ID: 35749612
[TBL] [Abstract][Full Text] [Related]
10. Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice.
Amin A; Choi SK; Galan M; Kassan M; Partyka M; Kadowitz P; Henrion D; Trebak M; Belmadani S; Matrougui K
J Pathol; 2012 Jun; 227(2):165-74. PubMed ID: 22081301
[TBL] [Abstract][Full Text] [Related]
11. SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in
Korbut AI; Taskaeva IS; Bgatova NP; Muraleva NA; Orlov NB; Dashkin MV; Khotskina AS; Zavyalov EL; Konenkov VI; Klein T; Klimontov VV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340263
[TBL] [Abstract][Full Text] [Related]
12. Effect of Linagliptin on Incretin-axis and Glycaemic Variability in T1DM.
Mukherjee S; Bhadada SK; Sachdeva N; Badal D; Bhansali S; Dutta P; Bhansali A
J Assoc Physicians India; 2018 Jul; 66(7):28-32. PubMed ID: 31325257
[TBL] [Abstract][Full Text] [Related]
13. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.
Galán M; Kassan M; Choi SK; Partyka M; Trebak M; Henrion D; Matrougui K
Hypertension; 2012 Jul; 60(1):71-80. PubMed ID: 22665120
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress contributes to NMDA-induced pancreatic β-cell dysfunction in a CHOP-dependent manner.
Huang XT; Liu W; Zhou Y; Sun M; Sun CC; Zhang CY; Tang SY
Life Sci; 2019 Sep; 232():116612. PubMed ID: 31260687
[TBL] [Abstract][Full Text] [Related]
15. Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.
McGill JB; Yki-Järvinen H; Crowe S; Woerle HJ; von Eynatten M
Diab Vasc Dis Res; 2015 Jul; 12(4):249-57. PubMed ID: 25941160
[TBL] [Abstract][Full Text] [Related]
16. RNF186 impairs insulin sensitivity by inducing ER stress in mouse primary hepatocytes.
Tong X; Zhang Q; Wang L; Ji Y; Zhang L; Xie L; Chen W; Zhang H
Cell Signal; 2018 Dec; 52():155-162. PubMed ID: 30223017
[TBL] [Abstract][Full Text] [Related]
17. The effect of linagliptin on renal progression in type-2 diabetes mellitus patients with chronic kidney disease: A prospective randomized controlled study.
Yagoglu AI; Dizdar OS; Erdem S; Akcakaya B; Gunal AI
Nefrologia (Engl Ed); 2020; 40(6):664-671. PubMed ID: 32736891
[TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.
Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H
Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.
Zinman B; Ahrén B; Neubacher D; Patel S; Woerle HJ; Johansen OE
Can J Diabetes; 2016 Feb; 40(1):50-7. PubMed ID: 26474870
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated UPR and ER Stress Related to a Mutation in the
Yagil C; Varadi-Levi R; Ifrach C; Yagil Y
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
